Galvenize Therapeutics
Galvenize Therapeutics raises $100M Series C
Galvenize Therapeutics: Series C Funding Round
Galvenize Therapeutics has successfully raised $100M in Series C funding.
Company Overview
Developer of pulsed electric field therapies for cardiac ablation procedures
Funding Details
The Series C round was led by Sofinnova Partners.
Company Information
- Headquarters: Redwood City, CA
- Founded: 2018
- Employees: 100+
- Category: HealthTech
Investment
Galvenize Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Sofinnova Partners: Verified investor in Series C
Company Info
Investors (1)
Share
Related Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started